Back to Search
Start Over
Efficacy and toxicity of the DPCPX nanoconjugate drug study for the treatment of spinal cord injury in rats
- Source :
- Journal of applied physiology (Bethesda, Md. : 1985). 133(2)
- Publication Year :
- 2023
-
Abstract
- Effects of the Adenosine A1 blockade using 8-cyclopentyl-1,3-diprophyxanthine (DPCPX) nanoconjugate on inducing recovery of the hemidiaphragm paralyzed by hemisection have been thoroughly examined previously; however, the toxicology of DPCPX nanoconjugate remains unknown. This research study investigates the therapeutic efficacy and toxicology of the nanoconjugate DPCPX in the cervical spinal cord injury (SCI) rat model. We hypothesized that a single injection of nanoconjugate DPCPX in the paralyzed left hemidiaphragm (LDH) of hemisected rats at the 2nd cervical segment (C2Hx) would lead to the long-term recovery of LDH while showing minimal toxicity. Adult male rats underwent left C2Hx surgery and the diaphragms' baseline electromyography (EMG). Subsequently, rats were randomized into a control group and four treated subgroups. Three subgroups received a single intradiaphragmatic dose of either 0.09, 0.15, or 0.27 µg/kg, and one subgroup received 0.1 mg/kg of native DPCPX two times per day intravenously (i.v.) for 3 days (total 0.6 mg/kg). Rats were monitored for a total of 56 days. Compared with control, the treatment with nanoconjugate DPCPX at 0.09 µg/kg, 0.15 µg/kg, and 0.27 µg/kg doses elicited significant recovery of paralyzed LDH (i.e., 67% recovery at 8 wk) (
Details
- ISSN :
- 15221601
- Volume :
- 133
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of applied physiology (Bethesda, Md. : 1985)
- Accession number :
- edsair.doi.dedup.....289aa39407649fcb1842db0bbec2bcc7